Molecular analysis of SLC25A13 gene in human peripheral blood lymphocytes: Marked transcript diversity, and the feasibility of cDNA cloning as a diagnostic tool for citrin deficiency

Gene

Volumn 511, Issue 2, 2012, Pages 227-234

  Zhang, Zhan Hui ^a   Lin, Wei Xia ^a   Deng, Mei ^a   Zhao, Xin Jing ^a   Song, Yuan Zong ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Alternative splice variant; CDNA cloning; Citrin deficiency; Peripheral blood lymphocytes; SLC25A13

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE; ISOPROTEIN; MEMBRANE PROTEIN; SLC25A13 PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; CITRIN DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIRECT SEQUENCING; FEASIBILITY STUDY; FEMALE; GENE AMPLIFICATION; GENE DUPLICATION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRAHEPATIC CHOLESTASIS; MALE; MOLECULAR CLONING; MOLECULAR GENETICS; NEONATAL INTRAHEPATIC CHOLESTASIS CAUSED BY CITRIN DEFICIENCY; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; HUMANS; LYMPHOCYTES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MUTATION; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84868195653     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.049     Document Type: Article

References (49)

1. Ben-Shalom E., et al. Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. Mol. Genet. Metab. 2002, 77:202-208.
2. Chang Y.F., Imam J.S., Wilkinson M.F. The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem. 2007, 76:51-74.
3. den Dunnen J.T., Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat. 2000, 15:7-12.
4. den Dunnen J.T., Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum. Genet. 2001, 109:121-124.
5. Deng M., Zhao X.J., Yang Z.G., Song Y.Z. Identification of novel SLC25A13 variation/mutations in patients with neonatal intrahepatic cholestasis caused by Citrin deficiency. The AASPP-International Symposium on Citrin Deficiency in Matsumoto: Program books, Japan, Oct 6-7. Matsumoto 2011, 32.
6. Dimmock D., et al. Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet. Pediatrics 2007, 119:e773-e777.
7. Dimmock D., et al. Citrin deficiency, a perplexing global disorder. Mol. Genet. Metab. 2009, 96:44-49.
8. Fiermonte G., et al. A new Caucasian case of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD): a clinical, molecular, and functional study. Mol. Genet. Metab. 2011, 104:501-506.
9. Fu X.D. RNA splicing and processing. Lewin's Genes X 2011, 573-617. Jones and Bartlett Publishers, Sudbury. 10th ed. J.E. Krebs, E.S. Goldstein, S.T. Kilpatrick (Eds.).
10. Fu H.Y., Zhang S.R., Wang X.H., Saheki T., Kobayashi K., Wang J.S. The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia. J. Gastroenterol. 2011, 46:510-518.
11. Green R.E., et al. Widespread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes. Bioinformatics 2003, 19:i118-i121.
12. Hansen K.D., et al. Genome-wide identification of alternative splice forms down-regulated by nonsense-mediated mRNA decay in Drosophila. PLoS Genet. 2009, 5:e1000525.
13. Iida A., Nakamura Y. Identification of 156 novel SNPs in 29 genes encoding G-protein coupled receptors. J. Hum. Genet. 2005, 50:182-191.
14. Kikuchi A., et al. Simple and rapid genetic testing for citrin deficiency by screening 11 prevalent mutations in SLC25A13. Mol. Genet. Metab. 2012, 105:553-558.
15. Klein R.J., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
16. Kobayashi K., Saheki T. Aspartate glutamate carrier (citrin) deficiency. Membrane Transporter Diseases, NY 2003, 147-160. Kluwer Academic/Plenum Publishers, New York. S. Broer, C.S. Wagner (Eds.).
17. Kobayashi K., et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat. Genet. 1999, 22:159-163.
18. TM [Internet] 2012, University of Washington, Seattle, Seattle (WA), (1993-. 2005 Sep 16 [Updated 2012 Jan 5]). R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens (Eds.).
19. Komatsu M., et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J. Hepatol. 2008, 49:810-820.
20. Lejeune F., Maquat L.E. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr. Opin. Cell Biol. 2005, 17:309-315.
21. Lewis B.P., Green R.E., Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:189-192.
22. Lin W.X., Zhang Z.H., Deng M., Cai X.R., Song Y.Z. Multiple ovarian antral follicles in a preterm infant with intrahepatic cholestasis caused by citrin deficiency. Gene 2012, 505:269-275.
23. Lu Y.B., et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J. Hum. Genet. 2005, 50:338-346.
24. McGlincy N.J., Smith C.W. Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense?. Trends Biochem. Sci. 2008, 33:385-393.
25. Ohura T., Kobayashi K., Tazawa Y., Abukawa D., Sakamoto O., Tsuchiya S., Saheki T. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). J. Inherit. Metab. Dis. 2007, 30:139-144.
26. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J. 2001, 20:5060-5069.
27. Pan Q., Shai O., Lee L.J., Frey B.J., Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40:1413-1415.
28. Saheki T., Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J. Hum. Genet. 2002, 47:333-341.
29. Saheki T., Kobayashi K. Physiological role of citrin, a liver-type mitochondrial aspartate-glutamate carrier, and pathophysiology of citrin deficiency. Recent Res. Dev. Life Sci. 2005, 3:59-73.
30. Saheki T., et al. Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency. Metab. Brain Dis. 2002, 17:335-346.
31. Saheki T., et al. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. Mol. Genet. Metab. 2004, 81:S20-S26.
32. Saheki T., Kobayashi K., Iijima M., Li M.X., Horiuchi M., Tabata A. Pathophysiology of citrin deficiency. Hepatic Encephalopathy and Nitrogen Metabolism 2006, 320-328. Springer, Dordrecht, Netherlands. D. Haussinger, G. Kircheis, F. Schliess (Eds.).
33. Saheki T., et al. Metabolomic analysis reveals hepatic metabolite perturbations in citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mice, a model of human citrin deficiency. Mol. Genet. Metab. 2011, 104:492-500.
34. Smyth D.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 2006, 38:617-619.
35. Song Y.Z., et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China. Dig. Liver Dis. 2009, 41:683-689.
36. Song Y.Z., Guo L., Yang Y.L., Han L.S., Kobayashi K., Saheki T. Failure to thrive and dyslipidemia caused by citrin deficiency: a novel clinical phenotype. Zhongguo Dang Dai Er Ke Za Zhi 2009, 11:328-332. (Article in Chinese).
37. Song Y.Z., et al. Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center. Int. J. Mol. Med. 2011, 28:33-40.
38. Stitziel N.O., Tseng Y.Y., Pervouchine D., Goddeau D., Kasif S., Liang J. Structural location of disease-associated single-nucleotide polymorphisms. J. Mol. Biol. 2003, 327:1021-1030.
39. Tabata A., et al. Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency. J. Hum. Genet. 2008, 53:534-545.
40. Takaya J., et al. Variant clinical courses of 2 patients with neonatal intrahepatic cholestasis who have a novel mutation of SLC25A13. Metabolism 2005, 54:1615-1619.
41. Tazawa Y., et al. Clinical heterogeneity of neonatal intrahepatic cholestasis caused by citrin deficiency: case reports from 16 patients. Mol. Genet. Metab. 2004, 83:213-219.
42. Thong M.K., Boey C.C., Sheng J.S., Ushikai M., Kobayashi K. Neonatal intrahepatic cholestasis caused by citrin deficiency in two Malaysian siblings: outcome at one year of life. Singap. Med. J. 2010, 51:e12-e14.
43. Tokuhara D., et al. Novel diagnostic approach to citrin deficiency: analysis of citrin protein in lymphocytes. Mol. Genet. Metab. 2007, 90:30-36.
44. Wang Z., Moult J. SNPs, protein structure, and disease. Hum. Mutat. 2001, 17:263-270.
45. Wang E.T., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
46. Wongkittichote P., Jensen L.T., Tungpradapkul S., Wattanasirichaigoon D. Functional analysis of citrin genetic variants from Thai patients with citrin deficiency: the use of a yeast model system. 9th Asian- Pacific conference on human genetics: Program book, China, Nov 30-Dec 3. Hong Kong 2010, 163.
47. Wongkittichote P., Jensen L.T., Tungpradapkul S., Wattanasirichaigoon D. Functional analysis of citrin mutations using a yeast model system. The AASPP-International Symposium on Citrin Deficiency in Matsumoto:Program books, Japan, Oct 6-7. Matsumoto 2011, 26.
48. Yamaguchi N., et al. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum. Mutat. 2002, 19:122-130.
49. Yeh J.N., Jeng Y.M., Chen H.L., Ni Y.H., Hwu W.L., Chang M.H. Hepatic steatosis and neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) in Taiwanese infants. J. Pediatr. 2006, 148:642-646.